Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the EBITDA margin high or low?
The EBITDA margin of 24.22% is 33% below its 5-year average of 36.07%, near the low end of its 5-year range (19.92%–48.98%).
As of the fiscal period ended Tuesday, June 30, 2026. 26.73% below its 12-month average of 33.06%.
Reported quarterly EBITDA margin; no daily interpolation.
EBITDA MARGIN
24.22%
EBITDA MARGIN AVG TTM
33.06%
EBITDA MARGIN AVG 3Y
36.55%
EBITDA MARGIN AVG 5Y
36.07%
EBITDA MARGIN AVG 10Y
N/A
EBITDA MARGIN AVG 15Y
N/A
EBITDA MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
-26.73%
CURRENT VS 3Y AVG
-33.74%
CURRENT VS 5Y AVG
-32.85%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Market Cap
$3.19B
EBITDA Margin
22.42%
TTM Avg
17.70%
3Y Avg
-0.76%
5Y Avg
-37.34%
Market Cap
$6.65B
EBITDA Margin
6.82%
TTM Avg
6.08%
3Y Avg
-0.44%
5Y Avg
-8.67%
Market Cap
$2.19B
EBITDA Margin
16.41%
TTM Avg
1.22%
3Y Avg
-1.65%
5Y Avg
4.31%
Market Cap
$8.10B
EBITDA Margin
-3.14%
TTM Avg
-1.08%
3Y Avg
-5.02%
5Y Avg
-19.32%
Market Cap
$1.15B
EBITDA Margin
3.96%
TTM Avg
-13.21%
3Y Avg
-146.19%
5Y Avg
-104.68%
Market Cap
$465.16M
EBITDA Margin
-48.80%
TTM Avg
-44.09%
3Y Avg
-45.35%
5Y Avg
-45.35%
| NAME | MARKET CAP | EBITDA MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Doximity, Inc. (DOCS) | $4.63B | 24.22% | 33.06% | 36.55% | 36.07% |
| TransMedics Group, Inc. (TMDX)vs › | $3.19B | 22.42% | 17.70% | -0.76% | -37.34% |
| Hims & Hers Health, Inc. (HIMS)vs › | $6.65B | 6.82% | 6.08% | -0.44% | -8.67% |
| DENTSPLY SIRONA Inc. (XRAY)vs › | $2.19B | 16.41% | 1.22% | -1.65% | 4.31% |
| Oscar Health, Inc. (OSCR)vs › | $8.10B | -3.14% | -1.08% | -5.02% | -19.32% |
| Teladoc Health, Inc. (TDOC)vs › | $1.15B | 3.96% | -13.21% | -146.19% | -104.68% |
| NRC Health (NRC)vs › | $495.81M | 21.99% | 25.40% | 28.98% | 31.97% |
| Shoulder Innovations, Inc. (SI)vs › | $465.16M | -48.80% | -44.09% | -45.35% | -45.35% |
| Insulet Corp. (PODD)vs › | $9.93B | 21.67% | 20.24% | 16.36% | 15.66% |
| Henry Schein, Inc. (HSIC)vs › | $10.30B | 8.11% | 8.11% | 8.28% | 8.19% |
Gross Margin
88.1%
EBITDA Margin
24.2%
Operating Margin
29.6%
Net Margin
25.5%
Formula: EBITDA Margin = (EBITDA / Revenue) × 100
Why EBITDA Margin matters:
EBITDA Margin = EBITDA / Revenue
EBITDA margin measures operating profitability before interest, taxes, depreciation, and amortization as a percentage of revenue.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EBITDA MARGIN |
|---|---|
| 2026-06-30 | 24.22% |
| 2026-03-31 | 19.92% |
| 2025-12-31 | 41.01% |
| 2025-09-30 | 40.85% |
| 2025-06-30 | 39.28% |
| 2025-03-31 | 37.25% |
| 2024-12-31 | 48.98% |
| 2024-09-30 | 40.75% |
| 2024-06-30 | 38.38% |
| 2024-03-31 | 37.61% |
| 2023-12-31 | 45.13% |
| 2023-09-30 | 32.04% |
| 2023-06-30 | 29.77% |
| 2023-03-31 | 32.04% |
| 2022-12-31 | 35.66% |
| 2022-09-30 | 33.95% |
| 2022-06-30 | 26.54% |
| 2022-03-31 | 31.27% |
| 2021-12-31 | 37.96% |
| 2021-09-30 | 32.90% |
| 2021-06-30 | 35.82% |
| 2021-03-31 | 34.85% |
| 2020-12-31 | 32.28% |
| 2020-09-30 | 25.19% |
| 2020-06-30 | 7.84% |
| 2020-03-31 | 32.63% |
| 2019-12-31 | 23.47% |
